Specifically, UBE2NL expression was significantly higher in advanced-stage ovarian cancer tissues compared to early-stage cancer and benign ovarian cysts (mean ± SD: 0.1225 ± 0.2508 vs. 0.0862 ± 0.1662 vs. 0.0037 ± 0.0069; p < 0.001, by Kruskal–Wallis test). This evidence concerns the gene UBE2NL and ovarian cancer.